Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer.
Saved in:
| Title: | Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer. |
|---|---|
| Authors: | Bouche O; CHU Reims, Reims, France. obouche@chu-reims.fr, Maindrault-Goebel F, Ducreux M, Lledo G, Andre T, Stopfer P, Amellal N, Merger M, De Gramont A |
| Source: | Anticancer research [Anticancer Res] 2011 Jun; Vol. 31 (6), pp. 2271-81. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 21737652 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bouche+O%22">Bouche O</searchLink>; CHU Reims, Reims, France. obouche@chu-reims.fr<br /><searchLink fieldCode="AU" term="%22Maindrault-Goebel+F%22">Maindrault-Goebel F</searchLink><br /><searchLink fieldCode="AU" term="%22Ducreux+M%22">Ducreux M</searchLink><br /><searchLink fieldCode="AU" term="%22Lledo+G%22">Lledo G</searchLink><br /><searchLink fieldCode="AU" term="%22Andre+T%22">Andre T</searchLink><br /><searchLink fieldCode="AU" term="%22Stopfer+P%22">Stopfer P</searchLink><br /><searchLink fieldCode="AU" term="%22Amellal+N%22">Amellal N</searchLink><br /><searchLink fieldCode="AU" term="%22Merger+M%22">Merger M</searchLink><br /><searchLink fieldCode="AU" term="%22De+Gramont+A%22">De Gramont A</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228102988%22">Anticancer research</searchLink> [Anticancer Res] 2011 Jun; Vol. 31 (6), pp. 2271-81. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22International+Institute+of+Anticancer+Research%22">International Institute of Anticancer Research </searchLink><i>Country of Publication: </i>Greece <i>NLM ID: </i>8102988 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1791-7530 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202507005%22">02507005 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21737652 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2271 Titles: – TitleFull: Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bouche O – PersonEntity: Name: NameFull: Maindrault-Goebel F – PersonEntity: Name: NameFull: Ducreux M – PersonEntity: Name: NameFull: Lledo G – PersonEntity: Name: NameFull: Andre T – PersonEntity: Name: NameFull: Stopfer P – PersonEntity: Name: NameFull: Amellal N – PersonEntity: Name: NameFull: Merger M – PersonEntity: Name: NameFull: De Gramont A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2011 Jun Type: published Y: 2011 Identifiers: – Type: issn-electronic Value: 1791-7530 Numbering: – Type: volume Value: 31 – Type: issue Value: 6 Titles: – TitleFull: Anticancer research Type: main |
| ResultId | 1 |